Relationship of serum antibiotic concentrations to nephrotoxicity in cancer patients receiving concurrent aminoglycoside and vancomycin therapy
- 1 December 1987
- journal article
- research article
- Published by Elsevier in The American Journal of Medicine
- Vol. 83 (6) , 1091-1097
- https://doi.org/10.1016/0002-9343(87)90947-8
Abstract
No abstract availableThis publication has 27 references indexed in Scilit:
- A Randomized Trial Comparing Ceftazidime Alone with Combination Antibiotic Therapy in Cancer Patients with Fever and NeutropeniaNew England Journal of Medicine, 1986
- Vancomycin enhancement of experimental tobramycin nephrotoxicityAntimicrobial Agents and Chemotherapy, 1986
- A prospective study of adverse reactions associated with vancomycin therapyJournal of Antimicrobial Chemotherapy, 1985
- Renal tolerance and pharmacokinetics of vancomycin in ratsJournal of Antimicrobial Chemotherapy, 1984
- Pharmacokinetics of vancomycin in patients with various degrees of renal functionAntimicrobial Agents and Chemotherapy, 1984
- RANDOMISED, CONTROLLED TRIAL OF THE COMPARATIVE EFFICACY, AUDITORY TOXICITY, AND NEPHROTOXICITY OF TOBRAMYCIN AND NETILMICINThe Lancet, 1983
- Pharmacokinetics of Vancomycin in Normal Subjects and in Patients with Reduced Renal FunctionClinical Infectious Diseases, 1981
- Toxicology of Vancomycin in Laboratory AnimalsClinical Infectious Diseases, 1981
- Double-Blind Comparison of the Nephrotoxicity and Auditory Toxicity of Gentamicin and TobramycinNew England Journal of Medicine, 1980
- Why Monitor Serum Levels of Gentamicin?Clinical Pharmacokinetics, 1978